Swiss to vote on stem cells

A national referendum to decide whether an embryonic stem cell law will take effect

Written byNed Stafford
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Voters in Switzerland will have the final say next month in a national referendum on whether a law already approved by Parliament allowing extraction of stem cells from surplus human embryos for research will be allowed to take effect.

The law was approved last December by the Swiss Parliament, despite opposition from the Green Party and anti-abortion groups. However, after passage of the law, opposition groups were able to collect enough signatures to force a nationwide referendum on the issue.

The Swiss government has launched a campaign advocating support for the new law, which also is backed by Switzerland's science and research organizations.

Margrit Leuthold, secretary general of the Swiss Academy of Medical Sciences, told The Scientist: "I think for the moment, and in view of the political situation, we are quite happy with this law."

The original bill proposed in Parliament would have allowed not only production of embryonic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform